246 related articles for article (PubMed ID: 17878750)
1. Therapeutic potential of tetrahydrobiopterin for treating vascular and cardiac disease.
Moens AL; Kass DA
J Cardiovasc Pharmacol; 2007 Sep; 50(3):238-46. PubMed ID: 17878750
[TBL] [Abstract][Full Text] [Related]
2. Tetrahydrobiopterin and cardiovascular disease.
Moens AL; Kass DA
Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2439-44. PubMed ID: 16946131
[TBL] [Abstract][Full Text] [Related]
3. Targeting endothelial and myocardial dysfunction with tetrahydrobiopterin.
Moens AL; Kietadisorn R; Lin JY; Kass D
J Mol Cell Cardiol; 2011 Oct; 51(4):559-63. PubMed ID: 21458460
[TBL] [Abstract][Full Text] [Related]
4. Tetrahydrobiopterin: pleiotropic roles in cardiovascular pathophysiology.
Cunnington C; Channon KM
Heart; 2010 Dec; 96(23):1872-7. PubMed ID: 20837663
[TBL] [Abstract][Full Text] [Related]
5. Tetrahydrobiopterin: regulator of endothelial nitric oxide synthase in vascular disease.
Channon KM
Trends Cardiovasc Med; 2004 Nov; 14(8):323-7. PubMed ID: 15596110
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms for the role of tetrahydrobiopterin in endothelial function and vascular disease.
Schmidt TS; Alp NJ
Clin Sci (Lond); 2007 Jul; 113(2):47-63. PubMed ID: 17555404
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide synthase uncoupling: a therapeutic target in cardiovascular diseases.
Roe ND; Ren J
Vascul Pharmacol; 2012; 57(5-6):168-72. PubMed ID: 22361333
[TBL] [Abstract][Full Text] [Related]
8. (6R)-5,6,7,8-tetrahydro-L-biopterin and its stereoisomer prevent ischemia reperfusion injury in human forearm.
Mayahi L; Heales S; Owen D; Casas JP; Harris J; MacAllister RJ; Hingorani AD
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1334-9. PubMed ID: 17413035
[TBL] [Abstract][Full Text] [Related]
9. Maintenance of cellular tetrahydrobiopterin homeostasis.
Kim HL; Park YS
BMB Rep; 2010 Sep; 43(9):584-92. PubMed ID: 20846489
[TBL] [Abstract][Full Text] [Related]
10. Tetrahydrobiopterin: biochemistry and pathophysiology.
Werner ER; Blau N; Thöny B
Biochem J; 2011 Sep; 438(3):397-414. PubMed ID: 21867484
[TBL] [Abstract][Full Text] [Related]
11. The eNOS cofactor tetrahydrobiopterin improves endothelial dysfunction in livers of rats with CCl4 cirrhosis.
Matei V; Rodríguez-Vilarrupla A; Deulofeu R; Colomer D; Fernández M; Bosch J; Garcia-Pagán JC
Hepatology; 2006 Jul; 44(1):44-52. PubMed ID: 16799985
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide and vascular insulin resistance.
Wu G; Meininger CJ
Biofactors; 2009; 35(1):21-7. PubMed ID: 19319842
[TBL] [Abstract][Full Text] [Related]
13. Folic acid reverses endothelial dysfunction induced by inhibition of tetrahydrobiopterin biosynthesis.
Moat SJ; Clarke ZL; Madhavan AK; Lewis MJ; Lang D
Eur J Pharmacol; 2006 Jan; 530(3):250-8. PubMed ID: 16387296
[TBL] [Abstract][Full Text] [Related]
14. The protective effect of tetrahydrobiopterin on the nitric oxide-mediated inhibition of purified nitric oxide synthase.
Hyun J; Komori Y; Chaudhuri G; Ignarro LJ; Fukuto JM
Biochem Biophys Res Commun; 1995 Jan; 206(1):380-6. PubMed ID: 7529500
[TBL] [Abstract][Full Text] [Related]
15. [Tetrahydrobiopterin Synthesis and Biological Function].
Wang ZF; Chen Jin-Wen ; Tie L; Li XJ
Sheng Li Ke Xue Jin Zhan; 2015 Aug; 46(4):259-64. PubMed ID: 26669076
[TBL] [Abstract][Full Text] [Related]
16. Endothelial nitric oxide synthase in vascular disease: from marvel to menace.
Förstermann U; Münzel T
Circulation; 2006 Apr; 113(13):1708-14. PubMed ID: 16585403
[TBL] [Abstract][Full Text] [Related]
17. Novel therapies targeting vascular endothelium.
Tousoulis D; Antoniades C; Koumallos N; Marinou K; Stefanadi E; Latsios G; Stefanadis C
Endothelium; 2006; 13(6):411-21. PubMed ID: 17169773
[TBL] [Abstract][Full Text] [Related]
18. Tetrahydrobiopterin Protects Against Hypertrophic Heart Disease Independent of Myocardial Nitric Oxide Synthase Coupling.
Hashimoto T; Sivakumaran V; Carnicer R; Zhu G; Hahn VS; Bedja D; Recalde A; Duglan D; Channon KM; Casadei B; Kass DA
J Am Heart Assoc; 2016 Mar; 5(3):e003208. PubMed ID: 27001967
[TBL] [Abstract][Full Text] [Related]
19. CO exchange of the oxyferrous complexes of endothelial nitric-oxide synthase oxygenase domain in the presence of 4-amino-tetrahydrobiopterin.
Marchal S; Lange R; Sørlie M; Andersson KK; Gorren AC; Mayer B
J Inorg Biochem; 2004 Jul; 98(7):1217-22. PubMed ID: 15219988
[TBL] [Abstract][Full Text] [Related]
20. Effects of tetrahydrobiopterin on coronary vascular reactivity in atherosclerotic human coronary arteries.
Worthley MI; Kanani RS; Sun YH; Sun Y; Goodhart DM; Curtis MJ; Anderson TJ
Cardiovasc Res; 2007 Dec; 76(3):539-46. PubMed ID: 17689509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
